Business

Abattis Confirms Breakthrough Extraction Technology Capabilities

Abattis Confirms Breakthrough Extraction Technology Capabilities.

articleAbattis Bioceuticals CorpDecember 12, 20173/company/abattis-bioceuticals-corp/news/abattis-confirms-breakthrough-extraction-technology-capabilities
Abattis Confirms Breakthrough Extraction Technology Capabilities

About this update from Abattis Bioceuticals Corp

[{"type":"text","content":"\n\n VANCOUVER, British Columbia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the \"Company\" or \"Abattis\") (CSE:ATT) (OTC:ATTBF) is pleased to announce the successful completion of experiments confirming column chromatography extraction technology.\n The experiments assessed the feasibility of applying the technology for the extraction of CBD, THC and THCA from industrial hemp and cannabis.  Throughputs, yields, purity and terpene profiles were also part of the scope of work performed at our facility, Northern Vine Labs.  Bench scale runs were carried out in conjunction with confirmatory larger scale runs of up to 75 kilograms of biomass per day.  The technology is already being used in an industrial scale capacity of up to 50,000 kilograms of biomass per day. The developer of the technology is now preparing to work with key partners to start isolating cannabinoids for the upcoming Canadian legalized market. “The extraction method using proprietary polymers has very distinct competitive advantages over traditional methods,” said Rob Abenante, President and CEO of Abattis.  “The technology is capable of extraction on an industrial scale, which delivers significant cost advantages.  It is also capable of separating cannabinoids on a molecular level which allows for the extraction of pure isolates such as CBD and THCA and even the separation pesticides from the biomass.” Proof of Concept Abattis confirms the following results from performed by the technology owner, Frank Zhu and his team: The quantitative recovery measurement showed 99% recovery of all cannabinoids from the biomass material.  These yields are better than conventional methods that generally only yield up to 80%.Confirmed separation of THC, THCA and CBD from a series of cannabis strains.Confirmed separation and production of pure 98%+ THCA in crystallized form.The technology successfully removes all traces of any pesticides or harmful residues from the cultivation and transportation process.Once commercialized, a factory running at a 500 kg-per-day processing rate can process CBD at less than $0.20/gram.The cost of capital equipment and overall cost of operation is less than half of conventional CO2 processes. “We have enjoyed our collaboration with Mr. Zhu. It has been an honor to have ...

More updates from Abattis Bioceuticals Corp